Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma Patients with ...

Patients with active cancer have an increased risk of venous thromboembolism, which results in substantial morbidity, mortality, and health care expenditures. The Khorana score (range, 0 to 6, with ...

Please provide your email address to receive an email when new articles are posted on . Using data from the US Renal Data System, researchers identified 74,194 Medicare-eligible patients who initiated ...

Please provide your email address to receive an email when new articles are posted on . Patient factors may have a greater impact on venous thromboembolism risk in those having total joint ...